OBJECTIVE To report a rare cause of cerebrospinal fluid ascites. METHODS A 37-year-old female with history of intracranial hypertension and a ventriculo-peritoneal shunt was referred to liver clinic for evaluation of newly developed ascites. RESULTS Initially, the cause of ascites was thought to be secondary to a liver etiology. However, this was excluded after a comprehensive evaluation in...

Purpose. We report a novel technique which aided recanalization of an occluded portal vein for transjugular intrahepatic portosystemic shunt (TIPS) creation in a patient with symptomatic portal vein thrombosis with cavernous transformation. Some have previously considered cavernous transformation a contraindication to TIPS. Case Presentation. 62-year-old man with chronic pancreatitis, portal ve...

Objective This preliminary study investigated the clinical safety and efficacy of foam sclerotherapy during shunt surgery to treat portal hypertension and gastroesophageal varices. Methods Seven patients with confirmed portal hypertension and a variceal bleeding history underwent mesocaval shunt with simultaneous polidocanol foam injection into the varices. Computed tomography and endoscopic ...

INTRODUCTION Due to the complexity of the surgical procedure portal vein thrombosis (PVT) has long been considered an absolute contraindication to liver transplantation (LT). The presence of a large splenorenal shunt (SRS) could make portal anastomosis a valid option. PRESENTATION OF CASE We report the case of a 37-year-old female patient with Grade III PVT and a large SRS, who underwent orth...

We present 2 patients showing afferent jejunal varix bleeding around hepaticojejunostomy caused by extrahepatic portal vein obstruction after pylorus-preserving pancreatoduodenectomy (PPPD). The case 1 was a 58-year-old woman who had recurrent anemia and hematochezia 3 years after undergoing PPPD. On the portography, the main portal vein was obliterated and collaterals around hepaticojejunostom...

Portal hypertension was recognized by the Greeks and was highlighted by Shakespeare in his character of Falstaff. 2,3 Surgery was the only treatment available for portal hypertension in the earlier times and the mortality rates were very high. In present times, about 10-15% of patients require surgery. With the development of the endoscopic treatment i.e. sclerotherapy, surgery no longer remain...

HAEMORRHAGE from cesophageal varices is a dreaded and frequently fatal complication of portal hypertension. In patients with cirrhosis the mortality within one year of the first hxmorrhage is from 25-75 per cent. The most effective way of preventing recurrent bleeding is reduction of the portal pressure by some form of portal-systemic shunt, but unfortunately there are patients where this is im...